TransCode Therapeutics Reports Second Quarter 2023 Results; Provides Business Update

Go back to TransCode Therapeutics Reports Second Quarter 2023 Results; Provides Business Update
(NASDAQ: RNAZ) Delayed: 1.68 -0.09 (5.08%)
Previous Close $1.77    52 Week High
Open $1.84    52 Week Low
Day High $2.39    P/E N/A 
Day Low $1.62    EPS
Volume 418,614